+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Global Biologic Therapeutics Market 2018-2022 - Product Image

Global Biologic Therapeutics Market 2018-2022

  • ID: 4722130
  • Report
  • December 2018
  • Region: Global
  • 120 pages
  • TechNavio
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

1 of 4

FEATURED COMPANIES

  • AbbVie
  • Johnson & Johnson
  • Merck
  • Pfizer
  • MORE
Increasing incidence of chronic diseases and immunological disorders to drive growth in the market. Biologics are ideal for the treatment of chronic disorders including cancer, autoimmune disorders, hormonal deficiencies, neurological disorders, and other critical conditions. The incidence of these diseases is rising significantly in developed nations. The increase in aging population and the lifestyle of people in these countries is responsible for the rise in occurrence of cancer, immunological disorders, and other chronic ailments. The analysts have predicted that the biologic therapeutics market will register a CAGR of over11% by 2022.

Market Overview

Increasing investment in development of biologics

Biotechnological products help manufacturers to earn huge revenues because of the therapeutic benefits they provide. Thus, many pharmaceutical companies are moving toward the development of biologics.

Reimbursement challenges of new biologics

The reimbursements available for biologics are very limited compared with that available for conventional therapeutics, despite the high costs. Manufacturers are providing biologics with mandatory companion diagnostics, which increases the overall cost of that biologic, making it difficult for insurers to provide reimbursements.

For the detailed list of factors that will drive and challenge the growth of the biologic therapeutics market during the 2018-2022, view this report.

Competitive Landscape

The market appears to be fragmented and with the presence of several companies including Merck and Pfizer, the competitive environment is quite intense. Factors such as the increasing incidence of chronic diseases and immunological disorders and the increasing investment in development of biologics, will provide considerable growth opportunities to biologic therapeutics manufactures. AbbVie, Johnson & Johnson, Merck, and Pfizer are some of the major companies covered in this report.
Note: Product cover images may vary from those shown
2 of 4

FEATURED COMPANIES

  • AbbVie
  • Johnson & Johnson
  • Merck
  • Pfizer
  • MORE
PART 01: EXECUTIVE SUMMARY

PART 02: SCOPE OF THE REPORT

PART 03: RESEARCH METHODOLOGY

PART 04: MARKET LANDSCAPE
  • Market ecosystem
  • Market characteristics
  • Market segmentation analysis
PART 05: PIPELINE ANALYSIS

PART 06: MARKET SIZING
  • Market definition
  • Market sizing 2017
  • Market size and forecast 2017-2022
PART 07: FIVE FORCES ANALYSIS
  • Bargaining power of buyers
  • Bargaining power of suppliers
  • Threat of new entrants
  • Threat of substitutes
  • Threat of rivalry
  • Market condition
PART 08: MARKET SEGMENTATION BY TYPE OF THERAPEUTIC AGENT
  • Segmentation by therapeutic agent
  • Comparison by therapeutic agent
  • Monoclonal antibodies - Market size and forecast 2017-2022
  • Others - Market size and forecast 2017-2022
  • Vaccines - Market size and forecast 2017-2022
  • Cell and tissue-based therapy - Market size and forecast 2017-2022
  • Gene therapy - Market size and forecast 2017-2022
  • Market opportunity by therapeutic agent
PART 09: MARKET SEGMENTATION BY APPLICATION
  • Oncology
  • Autoimmune and inflammatory diseases
  • Hematology
  • Others
PART 10: CUSTOMER LANDSCAPE

PART 11: REGIONAL LANDSCAPE
  • Geographical segmentation
  • Regional comparison
  • Americas - Market size and forecast 2017-2022
  • EMEA - Market size and forecast 2017-2022
  • APAC - Market size and forecast 2017-2022
  • Market opportunity
PART 12: DECISION FRAMEWORK

PART 13: DRIVERS AND CHALLENGES
  • Market drivers
  • Market challenges
PART 14: MARKET TRENDS

PART 15: VENDOR LANDSCAPE
  • Overview
  • Landscape disruption
PART 16: VENDOR ANALYSIS
  • Vendors covered
  • Vendor classification
  • Market positioning of vendors
  • AbbVie
  • Johnson & Johnson
  • Merck
  • Pfizer
PART 17: APPENDIX
  • List of abbreviations
List of Exhibits
Exhibit 01: Parent market
Exhibit 02: Global biologic therapeutics market: Segmentation
Exhibit 03: Market characteristics
Exhibit 04: Market segments
Exhibit 05: Biologics in pipeline 2017-2018
Exhibit 06: Market definition - Inclusions and exclusions checklist
Exhibit 07: Market size 2017
Exhibit 08: Validation techniques employed for market sizing 2017
Exhibit 09: Global - Market size and forecast 2017-2022 ($ bn)
Exhibit 10: Global - Year-over-year growth 2018-2022 (%)
Exhibit 11: Five forces analysis 2017
Exhibit 12: Five forces analysis 2022
Exhibit 13: Bargaining power of buyers
Exhibit 14: Bargaining power of suppliers
Exhibit 15: Threat of new entrants
Exhibit 16: Threat of substitutes
Exhibit 17: Threat of rivalry
Exhibit 18: Market condition - Five forces 2017
Exhibit 19: Global biologic therapeutics market - Market share by therapeutic agent 2017-2022 (%)
Exhibit 20: Comparison by therapeutic agent
Exhibit 21: Monoclonal antibodies - Market size and forecast 2017-2022 ($ bn)
Exhibit 22: Sales of major monoclonal antibodies 2015-2017
Exhibit 23: Monoclonal antibodies - Year-over-year growth 2018-2022 (%)
Exhibit 24: Others - Market size and forecast 2017-2022 ($ bn)
Exhibit 25: Others - Year-over-year growth 2018-2022 (%)
Exhibit 26: Vaccines - Market size and forecast 2017-2022 ($ bn)
Exhibit 27: Vaccines - Year-over-year growth 2018-2022 (%)
Exhibit 28: Cell and tissue-based therapy - Market size and forecast 2017-2022 ($ bn)
Exhibit 29: Cell and tissue-based therapy - Year-over-year growth 2018-2022 (%)
Exhibit 30: Gene therapy- Market size and forecast 2017-2022 ($ bn)
Exhibit 31: Gene therapy- Year-over-year growth 2018-2022 (%)
Exhibit 32: Market opportunity by type of therapeutic agent
Exhibit 33: Sales of biologics used in oncology 2015-2017 ($ millions)
Exhibit 34: Customer landscape
Exhibit 35: Global biologic therapeutics market - Market share by geography 2017-2022 (%)
Exhibit 36: Regional comparison
Exhibit 37: Americas - Market size and forecast 2017-2022 ($ bn)
Exhibit 38: Americas - Year-over-year growth 2018-2022 (%)
Exhibit 39: Top three countries in Americas
Exhibit 40: EMEA - Market size and forecast 2017-2022 ($ bn)
Exhibit 41: EMEA - Year-over-year growth 2018-2022 (%)
Exhibit 42: Top three countries in EMEA
Exhibit 43: APAC - Market size and forecast 2017-2022 ($ bn)
Exhibit 44: APAC - Year-over-year growth 2018-2022 (%)
Exhibit 45: Top three countries in APAC
Exhibit 46: Market opportunity
Exhibit 47: Treatment costs of some recently approved biologics in US
Exhibit 48: Patent expiration dates of some biologics
Exhibit 49: Vendor landscape
Exhibit 50: Landscape disruption
Exhibit 51: Vendor classification
Exhibit 52: Market positioning of vendors
Exhibit 53: AbbVie overview
Exhibit 54: AbbVie - Business segments
Exhibit 55: AbbVie - Organizational developments
Exhibit 56: AbbVie - Geographic focus
Exhibit 57: AbbVie - Key offerings
Exhibit 58: Johnson & Johnson overview
Exhibit 59: Johnson & Johnson - Business segments
Exhibit 60: Johnson & Johnson - Organizational developments
Exhibit 61: Johnson & Johnson Geographic focus
Exhibit 62: Johnson & Johnson - Segment focus
Exhibit 63: Johnson & Johnson - Key offerings
Exhibit 64: Merck overview
Exhibit 65: Merck - Business segments
Exhibit 66: Merck - Organizational developments
Exhibit 67: Merck - Geographic focus
Exhibit 68: Merck - Segment focus
Exhibit 69: Merck - Key offerings
Exhibit 70: Pfizer overview
Exhibit 71: Pfizer - Business segments
Exhibit 72: Pfizer - Organizational developments
Exhibit 73: Pfizer - Geographic focus
Exhibit 74: Pfizer - Segment focus
Exhibit 75: Pfizer - Key offerings
Note: Product cover images may vary from those shown
3 of 4

Loading
LOADING...

4 of 4

FEATURED COMPANIES

  • AbbVie
  • Johnson & Johnson
  • Merck
  • Pfizer
  • MORE
Global Biologic Therapeutics Market 2018-2022

The analyst recognizes the following companies as the key players in the global biologic therapeutics market: AbbVie, Johnson & Johnson, Merck, and Pfizer.

Commenting on the report, an analyst from the research team said: “The latest trend gaining momentum in the market is the increasing incidence of chronic diseases and immunological disorders.”

According to the report, one of the major drivers for this market is the increasing investment in development of biologics.

Further, the report states that one of the major factors hindering the growth of this market is the reimbursement challenges of new biologics.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.
Note: Product cover images may vary from those shown
5 of 4
  • AbbVie
  • Johnson & Johnson
  • Merck
  • Pfizer
Note: Product cover images may vary from those shown
Adroll
adroll